🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#DeepMeow #AIcat #StableDiffusion

What’s better than next generation sequencers? Our exceptional colleagues that run them with precision and determination! This #DNADay, we celebrate our creative RGCers who apply innovative technologies and scientific rigor to uncover the intricacies of DNA.

With Alnylam Pharmaceuticals, today we announced positive interim Phase 1 data for our jointly developed investigational RNAi therapeutic for #AlzheimersDisease.

#DeepMeow #AIcat #StableDiffusion

#DeepMeow #AIcat #StableDiffusion

“What is unequal and has always been unequal and is still unequal about Rosalind Franklin is the credit that she didn’t get in the aftermath of the discovery,” one historian said. nyti.ms/3oXKU3r

We’ve worked with UK Biobank to release the OMOP data conversion of the #genomics data resource, broadening access via the OHDSI data model widely used globally for open source data analysis tools.

We’re very proud to share that insitro CEO & Founder Daphne Koller has been elected to the National Academy of Sciences in recognition of her pioneering contributions to Machine Learning. Congratulations to Daphne and her distinguished peers for this prestigious recognition! #ML

#DeepMeow #AIcat #StableDiffusion

BREAKING: US Supreme Court issues unanimous opinion striking down Amgen’s PCSK9 patent claims and defending scientific innovation, ending nearly 10-year dispute related to Regeneron-invented medicine.

In 2022, our research in underrepresented populations and global collaborations allowed us to further our understanding of human genetics and biology. Championing transparency, we continue in our commitment to share genetic findings and increase access to diverse genomic data.

Regeneron is hiring a senior principal scientist to be a founding member of a novel research area focusing on endometriosis. Excited to hear about Regeneron's new preclinical research efforts in women's health and uterine/ovarian diseases.careers.regeneron.com/job/R23249/Sr-…

I know that too many people in the LGBTQI+ community are worried and afraid about their future and their safety. I want to send a message to the entire community – especially to transgender children. You are loved. You are heard. You are understood. You belong.

We're driven by our commitment to enhancing access to genomic data and findings with research communities #AroundTheWorld. Hear from UK Biobank’s Sir Rory Collins, FRS, FMedSci, on how our long-term collaboration accelerates discoveries to find determinants of disease.

"I'd be lion if I said this wasn't easy"

Since our inception, large-scale human genome sequencing has fueled our discovery, and needless to say, we’ve been busy. As we count down to a decade of team RGC, join us in reflecting on our sequencing milestones that helped us amass the world’s most diverse genetic database. 🌎

Today we, along with our collaborators at Unidad de Investigación en Medicina Experimental, Oxford Population Health (OxPop), AstraZeneca and @Abbvie are proud to share that our analysis of 140K individuals from the Mexico City Prospective Study (MCPS) has been published in nature. Explore the details: go.nature.com/3rStgzB

At the remarkable speed of today’s innovation, we’re seeing growth in how organizations leverage generative AI and data. Discover more in Databricks and MIT Technology Review’s latest global study, where our Chief Data Officer, Jeffrey G. Reid, shares our journey in data and AI transformation.

Come get to know team RGC and celebrate a decade of collaboration and exciting genetic discoveries. Sip, snack, and socialize at our #ASHG23 networking event this Friday night at the Marriott Marquis.

#ASHG23 RGC-ME is live!